学术探索
学术期刊
新闻热点
数据分析
智能评审
立即登录
CENTRAL-NERVOUS-SYSTEM TOXICITY OF QUINOLONES - HUMAN AND ANIMAL FINDINGS
被引:118
作者
:
CHRIST, W
论文数:
0
引用数:
0
h-index:
0
机构:
Institut für Arzneimittel des Bundesgesundheitsamles, Berlin, D-1000
CHRIST, W
机构
:
[1]
Institut für Arzneimittel des Bundesgesundheitsamles, Berlin, D-1000
来源
:
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
|
1990年
/ 26卷
关键词
:
D O I
:
10.1093/jac/26.suppl_B.219
中图分类号
:
R51 [传染病];
学科分类号
:
100401 ;
摘要
:
Quinolones have been reported to induce CNS reactions in 0.9–2.1% of cases, but severe reactions occur in less than 0.5%. Flumequine and fleroxacin, but not other quinolones, have produced convulsions in animals after systemic administration; by interventricular injection convulsions could be produced by some quinolones, but by pefloxacin only when a dose of 400 μg was reached. A possible mechanism for CNS excitation may be the displacement of GABA from receptors. Quinolones may interact with other drugs—theophylline, caffeine, non-steroidal anti-inflammatory drugs in producing CNS effects. © 1990 The British Society for Antimicrobial Chemotherapy.
引用
收藏
页码:219 / 225
页数:7
相关论文
共 30 条
[1]
STRUCTURE-EPILEPTOGENICITY RELATIONSHIP OF QUINOLONES WITH SPECIAL REFERENCE TO THEIR INTERACTION WITH GAMMA-AMINOBUTYRIC ACID RECEPTOR-SITES
AKAHANE, K
论文数:
0
引用数:
0
h-index:
0
AKAHANE, K
SEKIGUCHI, M
论文数:
0
引用数:
0
h-index:
0
SEKIGUCHI, M
UNE, T
论文数:
0
引用数:
0
h-index:
0
UNE, T
OSADA, Y
论文数:
0
引用数:
0
h-index:
0
OSADA, Y
[J].
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY,
1989,
33
(10)
: 1704
-
1708
[2]
NORFLOXACIN AND SEIZURES
ANASTASIO, GD
论文数:
0
引用数:
0
h-index:
0
ANASTASIO, GD
MENSCER, D
论文数:
0
引用数:
0
h-index:
0
MENSCER, D
LITTLE, JM
论文数:
0
引用数:
0
h-index:
0
LITTLE, JM
[J].
ANNALS OF INTERNAL MEDICINE,
1988,
109
(02)
: 169
-
170
[3]
ENOXACIN - A POTENT INHIBITOR OF THEOPHYLLINE METABOLISM
BECKMANN, J
论文数:
0
引用数:
0
h-index:
0
机构:
BUNDESGESUNDHEITSAMT,INST ARZNEIMITTEL,EXPTL & KLIN PHARMAKOL ABT,SEESTR 10,D-1000 BERLIN 65,FED REP GER
BUNDESGESUNDHEITSAMT,INST ARZNEIMITTEL,EXPTL & KLIN PHARMAKOL ABT,SEESTR 10,D-1000 BERLIN 65,FED REP GER
BECKMANN, J
ELSASSER, W
论文数:
0
引用数:
0
h-index:
0
机构:
BUNDESGESUNDHEITSAMT,INST ARZNEIMITTEL,EXPTL & KLIN PHARMAKOL ABT,SEESTR 10,D-1000 BERLIN 65,FED REP GER
BUNDESGESUNDHEITSAMT,INST ARZNEIMITTEL,EXPTL & KLIN PHARMAKOL ABT,SEESTR 10,D-1000 BERLIN 65,FED REP GER
ELSASSER, W
GUNDERTREMY, U
论文数:
0
引用数:
0
h-index:
0
机构:
BUNDESGESUNDHEITSAMT,INST ARZNEIMITTEL,EXPTL & KLIN PHARMAKOL ABT,SEESTR 10,D-1000 BERLIN 65,FED REP GER
BUNDESGESUNDHEITSAMT,INST ARZNEIMITTEL,EXPTL & KLIN PHARMAKOL ABT,SEESTR 10,D-1000 BERLIN 65,FED REP GER
GUNDERTREMY, U
HERTRAMPF, R
论文数:
0
引用数:
0
h-index:
0
机构:
BUNDESGESUNDHEITSAMT,INST ARZNEIMITTEL,EXPTL & KLIN PHARMAKOL ABT,SEESTR 10,D-1000 BERLIN 65,FED REP GER
BUNDESGESUNDHEITSAMT,INST ARZNEIMITTEL,EXPTL & KLIN PHARMAKOL ABT,SEESTR 10,D-1000 BERLIN 65,FED REP GER
HERTRAMPF, R
[J].
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY,
1987,
33
(03)
: 227
-
230
[4]
CHRIST W, 1988, NS ARCH PHARM S, V337
[5]
NORFLOXACIN - REVIEW OF SAFETY STUDIES
CORRADO, ML
论文数:
0
引用数:
0
h-index:
0
机构:
MERCK SHARP & DOHME RES LABS,WOODBRIDGE,NJ
MERCK SHARP & DOHME RES LABS,WOODBRIDGE,NJ
CORRADO, ML
STRUBLE, WE
论文数:
0
引用数:
0
h-index:
0
机构:
MERCK SHARP & DOHME RES LABS,WOODBRIDGE,NJ
MERCK SHARP & DOHME RES LABS,WOODBRIDGE,NJ
STRUBLE, WE
PETER, C
论文数:
0
引用数:
0
h-index:
0
机构:
MERCK SHARP & DOHME RES LABS,WOODBRIDGE,NJ
MERCK SHARP & DOHME RES LABS,WOODBRIDGE,NJ
PETER, C
HOAGLAND, V
论文数:
0
引用数:
0
h-index:
0
机构:
MERCK SHARP & DOHME RES LABS,WOODBRIDGE,NJ
MERCK SHARP & DOHME RES LABS,WOODBRIDGE,NJ
HOAGLAND, V
SABBAJ, J
论文数:
0
引用数:
0
h-index:
0
机构:
MERCK SHARP & DOHME RES LABS,WOODBRIDGE,NJ
MERCK SHARP & DOHME RES LABS,WOODBRIDGE,NJ
SABBAJ, J
[J].
AMERICAN JOURNAL OF MEDICINE,
1987,
82
(6B)
: 22
-
26
[6]
Esch B, 1989, Verh Dtsch Ges Inn Med, V95, P717
[7]
PEFLOXACIN - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE
GONZALEZ, JP
论文数:
0
引用数:
0
h-index:
0
GONZALEZ, JP
HENWOOD, JM
论文数:
0
引用数:
0
h-index:
0
HENWOOD, JM
[J].
DRUGS,
1989,
37
(05)
: 628
-
668
[8]
INHIBITION OF THEOPHYLLINE CLEARANCE BY COADMINISTERED OFLOXACIN WITHOUT ALTERATION OF THEOPHYLLINE EFFECTS
GREGOIRE, SL
论文数:
0
引用数:
0
h-index:
0
机构:
SUNY BUFFALO,DEPT PHARMACEUT,DIV CLIN PHARM SCI,BUFFALO,NY 14260
GREGOIRE, SL
GRASELA, TH
论文数:
0
引用数:
0
h-index:
0
机构:
SUNY BUFFALO,DEPT PHARMACEUT,DIV CLIN PHARM SCI,BUFFALO,NY 14260
GRASELA, TH
FREER, JP
论文数:
0
引用数:
0
h-index:
0
机构:
SUNY BUFFALO,DEPT PHARMACEUT,DIV CLIN PHARM SCI,BUFFALO,NY 14260
FREER, JP
TACK, KJ
论文数:
0
引用数:
0
h-index:
0
机构:
SUNY BUFFALO,DEPT PHARMACEUT,DIV CLIN PHARM SCI,BUFFALO,NY 14260
TACK, KJ
SCHENTAG, JJ
论文数:
0
引用数:
0
h-index:
0
机构:
SUNY BUFFALO,DEPT PHARMACEUT,DIV CLIN PHARM SCI,BUFFALO,NY 14260
SCHENTAG, JJ
[J].
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY,
1987,
31
(03)
: 375
-
378
[9]
GRUENE S, 1988, NS ARCH PHARM S, V338
[10]
EVALUATION OF THE EFFECT OF NORFLOXACIN ON THE PHARMACOKINETICS OF THEOPHYLLINE
HO, G
论文数:
0
引用数:
0
h-index:
0
机构:
OTTAWA GEN HOSP,DEPT PHARM,501 SMYTH RD,OTTAWA K1H 8L6,ONTARIO,CANADA
HO, G
TIERNEY, MG
论文数:
0
引用数:
0
h-index:
0
机构:
OTTAWA GEN HOSP,DEPT PHARM,501 SMYTH RD,OTTAWA K1H 8L6,ONTARIO,CANADA
TIERNEY, MG
DALES, RE
论文数:
0
引用数:
0
h-index:
0
机构:
OTTAWA GEN HOSP,DEPT PHARM,501 SMYTH RD,OTTAWA K1H 8L6,ONTARIO,CANADA
DALES, RE
[J].
CLINICAL PHARMACOLOGY & THERAPEUTICS,
1988,
44
(01)
: 35
-
38
←
1
2
3
→
共 30 条
[1]
STRUCTURE-EPILEPTOGENICITY RELATIONSHIP OF QUINOLONES WITH SPECIAL REFERENCE TO THEIR INTERACTION WITH GAMMA-AMINOBUTYRIC ACID RECEPTOR-SITES
AKAHANE, K
论文数:
0
引用数:
0
h-index:
0
AKAHANE, K
SEKIGUCHI, M
论文数:
0
引用数:
0
h-index:
0
SEKIGUCHI, M
UNE, T
论文数:
0
引用数:
0
h-index:
0
UNE, T
OSADA, Y
论文数:
0
引用数:
0
h-index:
0
OSADA, Y
[J].
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY,
1989,
33
(10)
: 1704
-
1708
[2]
NORFLOXACIN AND SEIZURES
ANASTASIO, GD
论文数:
0
引用数:
0
h-index:
0
ANASTASIO, GD
MENSCER, D
论文数:
0
引用数:
0
h-index:
0
MENSCER, D
LITTLE, JM
论文数:
0
引用数:
0
h-index:
0
LITTLE, JM
[J].
ANNALS OF INTERNAL MEDICINE,
1988,
109
(02)
: 169
-
170
[3]
ENOXACIN - A POTENT INHIBITOR OF THEOPHYLLINE METABOLISM
BECKMANN, J
论文数:
0
引用数:
0
h-index:
0
机构:
BUNDESGESUNDHEITSAMT,INST ARZNEIMITTEL,EXPTL & KLIN PHARMAKOL ABT,SEESTR 10,D-1000 BERLIN 65,FED REP GER
BUNDESGESUNDHEITSAMT,INST ARZNEIMITTEL,EXPTL & KLIN PHARMAKOL ABT,SEESTR 10,D-1000 BERLIN 65,FED REP GER
BECKMANN, J
ELSASSER, W
论文数:
0
引用数:
0
h-index:
0
机构:
BUNDESGESUNDHEITSAMT,INST ARZNEIMITTEL,EXPTL & KLIN PHARMAKOL ABT,SEESTR 10,D-1000 BERLIN 65,FED REP GER
BUNDESGESUNDHEITSAMT,INST ARZNEIMITTEL,EXPTL & KLIN PHARMAKOL ABT,SEESTR 10,D-1000 BERLIN 65,FED REP GER
ELSASSER, W
GUNDERTREMY, U
论文数:
0
引用数:
0
h-index:
0
机构:
BUNDESGESUNDHEITSAMT,INST ARZNEIMITTEL,EXPTL & KLIN PHARMAKOL ABT,SEESTR 10,D-1000 BERLIN 65,FED REP GER
BUNDESGESUNDHEITSAMT,INST ARZNEIMITTEL,EXPTL & KLIN PHARMAKOL ABT,SEESTR 10,D-1000 BERLIN 65,FED REP GER
GUNDERTREMY, U
HERTRAMPF, R
论文数:
0
引用数:
0
h-index:
0
机构:
BUNDESGESUNDHEITSAMT,INST ARZNEIMITTEL,EXPTL & KLIN PHARMAKOL ABT,SEESTR 10,D-1000 BERLIN 65,FED REP GER
BUNDESGESUNDHEITSAMT,INST ARZNEIMITTEL,EXPTL & KLIN PHARMAKOL ABT,SEESTR 10,D-1000 BERLIN 65,FED REP GER
HERTRAMPF, R
[J].
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY,
1987,
33
(03)
: 227
-
230
[4]
CHRIST W, 1988, NS ARCH PHARM S, V337
[5]
NORFLOXACIN - REVIEW OF SAFETY STUDIES
CORRADO, ML
论文数:
0
引用数:
0
h-index:
0
机构:
MERCK SHARP & DOHME RES LABS,WOODBRIDGE,NJ
MERCK SHARP & DOHME RES LABS,WOODBRIDGE,NJ
CORRADO, ML
STRUBLE, WE
论文数:
0
引用数:
0
h-index:
0
机构:
MERCK SHARP & DOHME RES LABS,WOODBRIDGE,NJ
MERCK SHARP & DOHME RES LABS,WOODBRIDGE,NJ
STRUBLE, WE
PETER, C
论文数:
0
引用数:
0
h-index:
0
机构:
MERCK SHARP & DOHME RES LABS,WOODBRIDGE,NJ
MERCK SHARP & DOHME RES LABS,WOODBRIDGE,NJ
PETER, C
HOAGLAND, V
论文数:
0
引用数:
0
h-index:
0
机构:
MERCK SHARP & DOHME RES LABS,WOODBRIDGE,NJ
MERCK SHARP & DOHME RES LABS,WOODBRIDGE,NJ
HOAGLAND, V
SABBAJ, J
论文数:
0
引用数:
0
h-index:
0
机构:
MERCK SHARP & DOHME RES LABS,WOODBRIDGE,NJ
MERCK SHARP & DOHME RES LABS,WOODBRIDGE,NJ
SABBAJ, J
[J].
AMERICAN JOURNAL OF MEDICINE,
1987,
82
(6B)
: 22
-
26
[6]
Esch B, 1989, Verh Dtsch Ges Inn Med, V95, P717
[7]
PEFLOXACIN - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE
GONZALEZ, JP
论文数:
0
引用数:
0
h-index:
0
GONZALEZ, JP
HENWOOD, JM
论文数:
0
引用数:
0
h-index:
0
HENWOOD, JM
[J].
DRUGS,
1989,
37
(05)
: 628
-
668
[8]
INHIBITION OF THEOPHYLLINE CLEARANCE BY COADMINISTERED OFLOXACIN WITHOUT ALTERATION OF THEOPHYLLINE EFFECTS
GREGOIRE, SL
论文数:
0
引用数:
0
h-index:
0
机构:
SUNY BUFFALO,DEPT PHARMACEUT,DIV CLIN PHARM SCI,BUFFALO,NY 14260
GREGOIRE, SL
GRASELA, TH
论文数:
0
引用数:
0
h-index:
0
机构:
SUNY BUFFALO,DEPT PHARMACEUT,DIV CLIN PHARM SCI,BUFFALO,NY 14260
GRASELA, TH
FREER, JP
论文数:
0
引用数:
0
h-index:
0
机构:
SUNY BUFFALO,DEPT PHARMACEUT,DIV CLIN PHARM SCI,BUFFALO,NY 14260
FREER, JP
TACK, KJ
论文数:
0
引用数:
0
h-index:
0
机构:
SUNY BUFFALO,DEPT PHARMACEUT,DIV CLIN PHARM SCI,BUFFALO,NY 14260
TACK, KJ
SCHENTAG, JJ
论文数:
0
引用数:
0
h-index:
0
机构:
SUNY BUFFALO,DEPT PHARMACEUT,DIV CLIN PHARM SCI,BUFFALO,NY 14260
SCHENTAG, JJ
[J].
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY,
1987,
31
(03)
: 375
-
378
[9]
GRUENE S, 1988, NS ARCH PHARM S, V338
[10]
EVALUATION OF THE EFFECT OF NORFLOXACIN ON THE PHARMACOKINETICS OF THEOPHYLLINE
HO, G
论文数:
0
引用数:
0
h-index:
0
机构:
OTTAWA GEN HOSP,DEPT PHARM,501 SMYTH RD,OTTAWA K1H 8L6,ONTARIO,CANADA
HO, G
TIERNEY, MG
论文数:
0
引用数:
0
h-index:
0
机构:
OTTAWA GEN HOSP,DEPT PHARM,501 SMYTH RD,OTTAWA K1H 8L6,ONTARIO,CANADA
TIERNEY, MG
DALES, RE
论文数:
0
引用数:
0
h-index:
0
机构:
OTTAWA GEN HOSP,DEPT PHARM,501 SMYTH RD,OTTAWA K1H 8L6,ONTARIO,CANADA
DALES, RE
[J].
CLINICAL PHARMACOLOGY & THERAPEUTICS,
1988,
44
(01)
: 35
-
38
←
1
2
3
→